Observational studyBMC infectious diseases2025
Clinical and inflammatory predictors of outpatient treatment failure in uncomplicated skin and soft tissue infections: a prospective multicenter study from Türkiye.
Observational study in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUncomplicated skin and soft tissue infections (uSSTIs) are highly prevalent; however, factors associated with outpatient treatment failure and subsequent hospitalization remain poorly defined in the existing literature. This prospective, multicenter observational study aimed to identify clinical and laboratory predictors of outpatient treatment failure in uSSTIs.
methodsAdult patients diagnosed with uSSTIs were enrolled from 24 infectious diseases departments across Türkiye between April 1st and September 30th, 2024, and their demographic, comorbidity, clinical, and laboratory data were systematically recorded. Hospitalization after initial outpatient therapy was considered a proxy for treatment failure, based on clinical judgment. Multivariable logistic regression was used to identify independent predictors of hospitalization following outpatient treatment failure, while receiver operating characteristic (ROC) analysis was performed to assess their discriminative performance.
resultsOf 599 patients, 263 completed outpatient therapy, 169 were hospitalized at presentation, and 167 required hospitalization after initial outpatient treatment. Univariate analysis identified higher body mass index (BMI, P = .015), chronic kidney disease (P = .044), immunodeficiency (P = .026), insect bite etiology (P = .047), and smoking (P = .019) as associated with hospitalization. Clinical predictors included lesion size > 10% body surface area (BSA, P < .001), and elevated pulse rate (P < .001). Laboratory predictors included elevated neutrophil-to-lymphocyte ratio (NLR > 4.37, P < .001), C-reactive protein (CRP > 67.5 mg/L, P < .001), and other inflammatory markers. Multivariable analysis confirmed smoking (OR: 3.403, 95% CI: 1.535-7.542), preseptal cellulitis (OR: 42.354, 95% CI: 4.178-429.336), lesion size > 10% BSA (OR: 3.898, 95% CI: 1.598-9.509), elevated CRP (OR: 1.005, 95% CI: 1.001-1.008), NLR (OR: 1.073, 95% CI: 1.012-1.138), and pulse rate (OR: 1.027, 95% CI: 1.004-1.051) as independent predictors. ROC analysis demonstrated moderate discriminative ability with AUC values for CRP, NLR, pulse rate of 0.695, 0.672 and 0.615, respectively.
conclusionsSmoking, preseptal cellulitis, extensive lesions, and elevated NLR, CRP, and pulse rate may be associated with an increased likelihood of hospitalization in patients with uSSTIs. Early identification may guide initial management, favoring intravenous therapy in high-risk patients to reduce treatment failure. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.